Insulin resistance in growth hormone-deficient adults: Defects in glucose utilization and glycogen synthase activity

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 555-564

  Hew, Fen Lee ^a,b   Koschmann, Marion ^a   Christopher, Michael ^a   Rantzau, Christian ^a   Vaag, Allan ^c   Ward, Glenn ^a,b   Beck Nielsen, Henning ^c   Alford, Frank ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLESTEROL; FATTY ACID; GLUCAGON; GLUCOSE; GLYCOGEN SYNTHASE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LACTIC ACID; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; MUSCLE BIOPSY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; FASTING; FEMALE; GLYCOGEN SYNTHASE; GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLES; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 9044222881     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.555     Document Type: Article

References (65)

1. Roth J, Grunfeld C. 1985 Mechanisms of action of peptide hormones and catecholamines. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology, 7th ed. Philadelphia: Saunders; 76-122.
2. Wolfsdorf JI, Sadeghi-Hejad A, Senior B. 1983 Hypoketonaemia and age-related fasting hypoglycaemia in growth hormone deficiency. Metab Clin Exp. 32:457-462.
3. Merimee TJ, Felig P, Marliss E, Fineberg SE, Cahill GC. 1971 Glucose and lipid homeostasis in the absence of human growth hormone. J Clin Invest. 50:574-582.
4. Cuneo RC, Saloman F, McGauley GA, Sonksen PH. 1992 The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 37:387-397.
5. Hew FL, Koschmann M, Kreiger K, et al. 1995 Insulin tolerance test in patients with anterior pituitary hormone deficiency: reduced insulin sensitivity. Endocrinol Metab. 2:93-98.
6. O'Neal DN, Kalfas A, Dunning PL, et al. 1994 The effect of three months of recombinant human growth hormone (rhGH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults. J Clin Endocrinol Metab. 79:975-983.
7. Beshyah SA, Henderson A, Nithtyanathan R, Sharp P, Richmond W, Johnston DG. 1994 Metabolic abnormalities in growth hormone-deficient adults. II. Carbohydrate tolerance and lipid metabolism. Endocrinol Metab. 1:173-180.
8. deBoer H, Blok GJ, Voerman HJ, Philips M, Schouten JA. 1994 Serum lipid levels in growth hormone-deficient men. Metab Clin Exp. 43:199-203.
9. Rosen T, Bengtsson B-A. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
10. Reaven GM. 1988 Banting lecture. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
11. Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H. 1991 Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 34:239-245.
12. Vaag A, Henrikson JE, Beck-Nielsen H. 1992 Decreased insulin activation of glycogen synthase in skeletal muscles in young non obese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 89:782-788.
13. Rossetti L, Lee Y-T, Riniz J, Aldridge SC, Shamoon H, Boden G. 1993 Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol. 265:E761-E769.
14. Finegood DT, Bergman RN, Vranic M. 1987 Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabelled and labelled exogenous glucose infusates. Diabetes. 36:914-924.
15. Christopher MJ, Rantzau C, Ward GM, Alford FP. 1994 Impact of variable insulinemia and glycemia on in vivo glycolysis and glucose storage in dogs. Am J Physiol. 266:E62-E71.
16. Christopher MJ, Sleeman MW, Alford FP, Best JD. 1992 Contrasting action of short- and long-term adrenaline infusion on dog skeletal muscle glucose metabolism. Diabetologia. 35:399-405.
17. Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H. 1995 Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia. 38:327-336.
18. Schalin-Jantti C, Harkonen M, Groop LC. 1992 Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes. 41:598-604.
19. Evans DJ, Murray R, Kissebah AH. 1984 Relationship between skeletal muscle insulin resistance, insulin mediated glucose disposal and insulin binding: effects of obesity and body fat topography. J Clin Invest. 74:1515-1525.
20. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. 1985 Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 41:810-817.
21. Svendsen OL, Hassayer C, Bermann I, Christiansen C. 1993 Measurement of abdominal and intra-abdominal fat in post menopausal women by dual energy x-ray absorptiometry and anthropometry: comparison with computerised tomography. Int J Obes. 17:45-51.
22. Bergman RN, Hope ID, Yang YJ, et al. 1989 Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev. 5:411-429.
23. Molina JM, Baron AD, Edelman SV, Brechtel G, Wallace P, Olefsky JM. 1990 Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol. 258:E16-E23.
24. Ader M, Bergman RN. 1990 Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol. 258:E1020-E1032.
25. Martin IK, Weber KM, Boston RC, Alford FP, Best JD. 1988 Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs. Am J Physiol. 249:E668-E673.
26. Steele R, Wall JS, Debodo RC, Altszuler N. 1956 Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol. 187:E15-E24.
27. Radziuk J, Norwich KH, Vranic M. 1978 Experimental validation of measurements of glucose turnover in non steady state. Am J Physiol. 234:E84-E93.
28. Rossetti L, Giaccari A. 1990 Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest. 85:1785-1792.
29. King RFGL, Macfire J, Hill G. 1981 Activities of hexokinase, phosphofructokinase, fructose bisphosphatase and 2-oxoglutarate dehydrogenase in muscle of normal subjects and very ill surgical patients. Clin Sci. 60:451-456.
30. Noll F. 1984 L-(+)-Lactate. In: Bergmeyer HU, ed. Methods of enzymatic analysis. Germany: Verlag Chemie; vol 6:582-588.
31. Oskor H, Thomsen HG, Yde H. 1968 Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature. 219:193-195.
32. Gorski T, Mohr M. 1990 HbA1c by non dedicated HPLC compared with mini-column. In: Ryall RG, ed. Proceedings of Glycated Proteins in Diabetes Mellitus Symposium. Adelaide: University of Adelaide Press; 36-41.
33. Landon J, Greenwood FC, Stamp TCB, Wynn V. 1966 The plasma sugar, free fatty acid, cortisol and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest. 45:437-449.
34. Golay A, Felber JP, Jequier E, DeFronzo RA, Ferrannini E. 1988 Metabolic basis of obesity and non insulin-dependent diabetes mellitus. Diabetes Metab Rev. 4:727-747.
35. Bjorntorp P. 1991 Metabolic implications of body fat distribution. Diabetes Care. 14:1132-1143.
36. Olefsky JM, Reaven GM, Farquar JW. 1974 Effects of weight reduction on obesity: studies of carbohydrate and lipid metabolism. J Clin Invest. 53:64-76.
37. Del Prato S, Bonadonna RC, Bonora E, et al. 1993 Characterisation of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest. 91:484-494.
38. Haffner, SM, Karhapaa P, Mykkanen L, Laakso M. 1994 Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 43:212-219.
39. Zhou Y-P, Grill VE. 1994 Long term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest. 43:870-876.
40. Mandarino L, Wright K, Verity L, et al. 1987 Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase and glycogen synthase. J Clin Invest. 80:655-663.
41. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. 1990 Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Ann Intern Med. 113:909-915.
42. Randle PJ, Garland PB, Hales CN, Newsholme EA. 1963 The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 2:785-789.
43. Argyraki M, Wright PD, Venables CW, Proud G, Taylor R. 1989 In vitro human skeletal muscle strips: effect of nonesterified fatty acid supply on glucose storage. Metab Clin Exp. 38:1183-1187.
44. Boden G, Jadil F, White J, et al. 1991 Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest. 88:960-966.
45. Vaag A, Skott P, Damsbo P, Gall MA, Richter EA, Beck-Nielsen H. 1991 Effect of the antilipolytic nicotinic acid analogue acipimox on whole body and skeletal muscle glucose metabolism in patents with non-insulin-dependent diabetes mellitus. J Clin Invest. 88:1282-1290.
46. Wittsuwannakul D, Kim K. 1977 Mechanisms of palmityl co-enzyme A inhibition of liver glycogen synthase. J Biol Chem. 252:1812-1817.
47. Ginsberg BH, Browan TJ, Simon I, Spector AA. 1981 Effect of the membrane lipid environment on the properties of insulin receptors. Diabetes. 30:773-780.
48. Pelikanova T, Kohout M, Valek J, Base J, Kazdova L. 1989 Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metab Clin Exp. 38:188-192.
49. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. 1991 Influence of dietary fat composition on development of insulin resistance in rats. Diabetes. 40:280-289.
50. Cori CF. 1931 Mammalian carbohydrate metabolism. Physiol Rev. 11:143-275.
51. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. 1994 Diagnosis of growth-hormone deficiency in adults. Lancet. 343:1064-1068.
52. Ghigo E, Procopio M, Boffano GM, et al. 1992 Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metab Clin Exp. 41:560-563.
53. Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. 1994 The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin and growth hormone. Metab Clin Exp. 43:315-319.
54. Froesch ER, Zapf J. 1985 Insulin-like growth factors and insulin: comparative aspects. Diabetologia. 28:485-493.
55. Boulware SD, Tamborlane WV, Matthews LS, Sherwin RS. 1992 Diverse effects of insulin-like growth factor I on glucose, lipid and amino acid metabolism. Am. J. Physiol. 262:E130-E133.
56. Beshyah SA, Anyaoku V, Newton P, Johnston DG. 1994 Metabolic abnormalities in growth hormone deficient adults. I. Serum Insulin-like growth factor-I. Endocrinol Metab. 1:167-172.
57. Weaver JU, Monson JP, Noonan K, et al. 1995 The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab. 80:153-159.
58. Pestell R, Alford F, Ramos R, Sawyer S, Best J, Ward G. 1990 Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in thyrotoxicosis: a minimal model analysis. Clin Endocrinol (Oxf). 33:481-493.
59. Shen D-C, Davidson MB, Kuo S-W, Shen WH-H. 1988 Peripheral and hepatic insulin antagonism in hyperthyroidism. J Clin Endocrinol Metab. 66:565-569.
60. Rooney DP, Neely RDG, Cullen C, et al. 1993 The effect of cortisol on glucose/glucose-6-phosphate cycle activity and insulin action. J Clin Endocrinol Metab. 77:1180-1183.
61. McMahon M, Gerich J, Rizza R. 1988 Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev. 4:17-30.
62. Dineen S, Alzaid A, Miles J, Rizza R. 1993 Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J Clin Invest. 91:2283-2290.
63. Holmang A, Bjorntorp P. 1992 Effect of testosterone on muscle insulin sensitivity in male rats. Acta Physiol Scand. 146:505-510.
64. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. 1991 Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metab Clin Exp. 40:1323-1326.
65. Markusis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340:1188-1192.